Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Leonard T Heffner
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Geisinger Medical Center
Danville, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pennsylvania/abramson Cancer Center
Philadelphia, Pennsylvania, United States
- Gundersen Lutheran Medical Center
La Crosse, Wisconsin, United States
- Marshfield Medical Center-Marshfield
Marshfield, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
- Marshfield Clinic-Minocqua Center
Minocqua, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Jul 2011
- Primary completion
- 8 Dec 2014
- Completion
- 1 Sept 2021
- Last update posted
- 4 Oct 2021
- Registered enrollment
- 9
- Registry id
- NCT01381692
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.